Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 14/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.39 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22015695 | 0.80 | NOD1 (0.56) | NOD1FOLH1PTGS1GSTK1GLO1 | |
| SCHEMBL22015849 | 0.80 | NOD1 (0.56) | NOD1FOLH1PTGS1GSTK1GLO1 | |
| SCHEMBL20077214 | 0.77 | NOD1 (0.55) | NOD1FOLH1PTGS1GSTK1GLO1 | |
| SCHEMBL20077204 | 0.77 | NOD1 (0.55) | NOD1FOLH1PTGS1GSTK1GLO1 | |
| SCHEMBL22015951 | 0.76 | NOD1 (0.56) | NOD1FOLH1PTGS1GSTK1GLO1 | |
| SCHEMBL22015678 | 0.75 | NOD1 (0.52) | NOD1FOLH1PTGS1GSTK1GLO1 | |
| SCHEMBL22015669 | 0.75 | NOD1 (0.52) | NOD1FOLH1PTGS1GSTK1GLO1 | |
| SCHEMBL211038 | 0.74 | NOD1 (0.46) | NOD1FOLH1PTGS1GSTK1GLO1 | |
| SCHEMBL2639637 | 0.72 | NOD1 (0.49) | NOD1FOLH1PTGS1GSTK1GLO1 | |
| SCHEMBL7641414 | 0.72 | NOD1 (0.49) | NOD1FOLH1PTGS1GSTK1GLO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137742-A1 | Composition for Activating Transient Receptor Potential Ankyrin 1, and Composition for Enhancing Food Consumption and/or Ameliorating Decreased Appetite | HOUSE FOODS GROUP INC (JP) | 2026-05-21 | — | — | US | disclosed |
| EP-4613111-A1 | COMPOSITION FOR ACTIVATING TRANSIENT RECEPTOR POTENTIAL ANKYRIN 1, AND COMPOSITION FOR ENHANCING FOOD CONSUMPTION AND/OR AMELIORATING DECREASED APPETITE | House Foods Group Inc. (JP) | 2025-09-10 | — | — | EP | disclosed |
| JP-2024088524-A | FLAVOR IMPROVING AGENT | マッシュウェル株式会社 | 2024-07-02 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260137742-A1 | Composition for Activating Transient Receptor Potential Ankyrin 1, and Composition for Enhancing Food Consumption and/or Ameliorating Decreased Appetite | TRPA1, TRPV1, TRPV3 | NOD1 682/4885FOLH1 3781/4885PTGS1 3084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.